Ignite Creation Date:
2025-12-24 @ 3:04 PM
Ignite Modification Date:
2025-12-28 @ 2:28 AM
Study NCT ID:
NCT04554459
Status:
TERMINATED
Last Update Posted:
2024-08-14
First Post:
2020-09-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ponatinib Plus Reduced-intensity Chemotherapy in the First-line Treatment of Adult Patients With Ph+ ALL
Sponsor:
Institute of Hematology and Blood Transfusion, Czech Republic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-16
Start Date Type:
ACTUAL
Primary Completion Date:
2023-09-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-07-01
Completion Date Type:
ACTUAL
First Submit Date:
2020-09-04
First Submit QC Date:
None
Study First Post Date:
2020-09-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-13
Last Update Post Date:
2024-08-14
Last Update Post Date Type:
ACTUAL